{"transactions":[{"id":1220902,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock Options","published_at":"2025-03-06T22:47:59.000Z","date":"2025-03-05","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":8.35,"exercise_date":"2017-06-24","expiration_date":"2026-08-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-25-034960","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/718937/000095017025034960/ownership.xml","form_type":"4"}},{"id":1220901,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock Options","published_at":"2025-03-06T22:47:59.000Z","date":"2025-03-05","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.54,"exercise_date":"2017-06-24","expiration_date":"2026-06-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-25-034960","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/718937/000095017025034960/ownership.xml","form_type":"4"}},{"id":1220900,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-03-06T22:47:59.000Z","date":"2025-03-05","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":8.35,"value":83500.0,"ownership":{"direct":true},"balance_after":35156,"source":{"system":"sec-edgar","filing":"0000950170-25-034960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/718937/000095017025034960/ownership.xml","form_type":"4"}},{"id":1220899,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-03-06T22:47:59.000Z","date":"2025-03-05","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":5.54,"value":55400.0,"ownership":{"direct":true},"balance_after":25156,"source":{"system":"sec-edgar","filing":"0000950170-25-034960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000095017025034960/ownership.xml","form_type":"4"}},{"id":1239786,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-02-28T21:05:00.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs granted to the Reporting Person on February 26, 2025. RSUs will vest as to 1/3 of the shares subject to the award on Febraury 26, 2026, 2027 and 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs granted to the Reporting Person on February 26, 2025. RSUs will vest as to 1/3 of the shares subject to the award on Febraury 26, 2026, 2027 and 2028."}],"balance_after":200000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-25-029986","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000095017025029986/ownership.xml","form_type":"4"}},{"id":1471462,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-06-24T21:06:55.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects shares of restricted stock and options to purchase common stock granted on June 20, 2024, pursuant to the Corporation's annual non-employee director equity compensation program for the 2024-2025 term.  These equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders."}],"balance_after":4010,"derivative":{"exercise_price":40.11,"exercise_date":"2025-06-20","expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":4010},"source":{"system":"sec-edgar","filing":"0000950170-24-076869","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/718937/000095017024076869/ownership.xml","form_type":"4"}},{"id":1471461,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T21:06:55.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":2244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects shares of restricted stock and options to purchase common stock granted on June 20, 2024, pursuant to the Corporation's annual non-employee director equity compensation program for the 2024-2025 term.  These equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders."}],"balance_after":15156,"source":{"system":"sec-edgar","filing":"0000950170-24-076869","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000095017024076869/ownership.xml","form_type":"4"}},{"id":1697443,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-02T23:03:02.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":921,"price":31.21,"value":28744.41,"ownership":{"direct":true},"balance_after":12912,"source":{"system":"sec-edgar","filing":"0001209191-24-000221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919124000221/doc4.xml","form_type":"4"}},{"id":1749158,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-06T21:14:09.000Z","date":"2023-11-06","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":35.15,"value":105450.0,"ownership":{"direct":true},"balance_after":11991,"source":{"system":"sec-edgar","filing":"0001209191-23-054514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919123054514/doc4.xml","form_type":"4"}},{"id":1769509,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-04T00:07:17.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":715,"price":40.18,"value":28728.7,"ownership":{"direct":true},"balance_after":8991,"source":{"system":"sec-edgar","filing":"0001209191-23-051748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919123051748/doc4.xml","form_type":"4"}},{"id":1853553,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2023-06-17T00:41:13.000Z","date":"2023-06-15","kind":"exercise","planned":false,"acquired":true,"shares":3127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on the earlier of June 15, 2024 or the Corporation's 2024 Annual Shareholders Meeting, subject to his continued service through the vesting date."}],"balance_after":3127,"derivative":{"exercise_price":52.67,"exercise_date":"2024-06-15","expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":3127},"source":{"system":"sec-edgar","filing":"0001209191-23-038172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919123038172/doc4.xml","form_type":"4"}},{"id":1853552,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-17T00:41:13.000Z","date":"2023-06-15","kind":"exercise","planned":false,"acquired":true,"shares":1709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restrictions on the 1709 restricted shares of common stock lapse on the earlier of June 15, 2024 or the Corporation's 2024 Annual Meeting, subject to Mr. Farrell's continued service through that date."}],"balance_after":8276,"source":{"system":"sec-edgar","filing":"0001209191-23-038172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919123038172/doc4.xml","form_type":"4"}},{"id":2138181,"issuer":{"id":123140,"kind":"organization","name":"Convey Health Solutions Holdings, Inc.","symbol":"CNVY"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2022-10-12T19:26:16.000Z","date":"2022-10-07","kind":"disposition_to_issuer","acquired":false,"shares":355561,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding Company restricted stock units (\"RSUs\") remained outstanding and continue to be subject to the same terms and conditions as immediately prior to the Effective Time, as set forth in the applicable plan and award agreement, except that each such RSU will settle in a number of Surviving Corporation Shares equal to the number of shares subject to the award immediately before the Effective Time multiplied by 0.01."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Represents 355,561 RSUs. RSUs are subject to a four year time-based vesting schedule with 25% vesting on March 28, 2023, and the remainder vesting in 12 equal installments every three months thereafter, subject to Mr. Farrell's continued service through the applicable vesting date. Prior to the Effective Time, each RSU represented a contingent right to receive one share of Company common stock and settled in common stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding Company restricted stock units (\"RSUs\") remained outstanding and continue to be subject to the same terms and conditions as immediately prior to the Effective Time, as set forth in the applicable plan and award agreement, except that each such RSU will settle in a number of Surviving Corporation Shares equal to the number of shares subject to the award immediately before the Effective Time multiplied by 0.01."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Represents 355,561 RSUs. RSUs are subject to a four year time-based vesting schedule with 25% vesting on March 28, 2023, and the remainder vesting in 12 equal installments every three months thereafter, subject to Mr. Farrell's continued service through the applicable vesting date. Prior to the Effective Time, each RSU represented a contingent right to receive one share of Company common stock and settled in common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Represents 355,561 RSUs. RSUs are subject to a four year time-based vesting schedule with 25% vesting on March 28, 2023, and the remainder vesting in 12 equal installments every three months thereafter, subject to Mr. Farrell's continued service through the applicable vesting date. Prior to the Effective Time, each RSU represented a contingent right to receive one share of Company common stock and settled in common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.01 per share","underlying_shares":355561},"source":{"system":"sec-edgar","filing":"0000950103-22-017700","document":"dp182275_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1188757/000095010322017700/dp182275_4-farrell.xml","form_type":"4"}},{"id":2138180,"issuer":{"id":123140,"kind":"organization","name":"Convey Health Solutions Holdings, Inc.","symbol":"CNVY"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-12T19:26:16.000Z","date":"2022-10-07","kind":"disposition_to_issuer","acquired":false,"shares":975806,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's options to acquire Company common stock, whether vested or unvested, remained outstanding and continue to be subject to the same terms and conditions as immediately prior to the Effective Time, as set forth in the applicable plan and award agreement, except that: (i) each such option is exercisable for that number of Surviving Corporation Shares equal to the product of (A) the number of shares of Company common stock subject to the option immediately before the Effective Time multiplied by (B) 0.01; and (ii) the per share exercise price for each Surviving Corporation Share issuable upon exercise of such option is equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (A) the exercise price per share of such option immediately before the Effective Time by (B) 0.01."},{"field":"security","element":"securityTitle","label":"F5","text":"The options, together representing a right to purchase 1,501,240 shares, consist of (i) 750,620 time-vesting options and (ii) 750,620 performance-vesting options. Time-vesting options are subject to a five-year time-based vesting schedule, with 20% vesting on September 4, 2020 and the remainder vesting in 16 equal installments every three months thereafter. Performance-vesting options vest over a five-year performance period commencing in 2019, with 20% of the stock options eligible to vest each year of the performance period based on achievement of certain financial metrics."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Exercise price reflects a reduction of $1.18 per award from original exercise price of $7.94 as part of a special dividend as previously disclosed in the Company's proxy statement for its 2022 annual meeting of stockholders."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's options to acquire Company common stock, whether vested or unvested, remained outstanding and continue to be subject to the same terms and conditions as immediately prior to the Effective Time, as set forth in the applicable plan and award agreement, except that: (i) each such option is exercisable for that number of Surviving Corporation Shares equal to the product of (A) the number of shares of Company common stock subject to the option immediately before the Effective Time multiplied by (B) 0.01; and (ii) the per share exercise price for each Surviving Corporation Share issuable upon exercise of such option is equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (A) the exercise price per share of such option immediately before the Effective Time by (B) 0.01."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options, together representing a right to purchase 1,501,240 shares, consist of (i) 750,620 time-vesting options and (ii) 750,620 performance-vesting options. Time-vesting options are subject to a five-year time-based vesting schedule, with 20% vesting on September 4, 2020 and the remainder vesting in 16 equal installments every three months thereafter. Performance-vesting options vest over a five-year performance period commencing in 2019, with 20% of the stock options eligible to vest each year of the performance period based on achievement of certain financial metrics."}],"balance_after":0,"derivative":{"exercise_price":6.76,"expiration_date":"2030-03-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":975806},"source":{"system":"sec-edgar","filing":"0000950103-22-017700","document":"dp182275_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1188757/000095010322017700/dp182275_4-farrell.xml","form_type":"4"}},{"id":2138179,"issuer":{"id":123140,"kind":"organization","name":"Convey Health Solutions Holdings, Inc.","symbol":"CNVY"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-12T19:26:16.000Z","date":"2022-10-07","kind":"disposition_to_issuer","acquired":false,"shares":525434,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's options to acquire Company common stock, whether vested or unvested, remained outstanding and continue to be subject to the same terms and conditions as immediately prior to the Effective Time, as set forth in the applicable plan and award agreement, except that: (i) each such option is exercisable for that number of Surviving Corporation Shares equal to the product of (A) the number of shares of Company common stock subject to the option immediately before the Effective Time multiplied by (B) 0.01; and (ii) the per share exercise price for each Surviving Corporation Share issuable upon exercise of such option is equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (A) the exercise price per share of such option immediately before the Effective Time by (B) 0.01."},{"field":"security","element":"securityTitle","label":"F5","text":"The options, together representing a right to purchase 1,501,240 shares, consist of (i) 750,620 time-vesting options and (ii) 750,620 performance-vesting options. Time-vesting options are subject to a five-year time-based vesting schedule, with 20% vesting on September 4, 2020 and the remainder vesting in 16 equal installments every three months thereafter. Performance-vesting options vest over a five-year performance period commencing in 2019, with 20% of the stock options eligible to vest each year of the performance period based on achievement of certain financial metrics."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's options to acquire Company common stock, whether vested or unvested, remained outstanding and continue to be subject to the same terms and conditions as immediately prior to the Effective Time, as set forth in the applicable plan and award agreement, except that: (i) each such option is exercisable for that number of Surviving Corporation Shares equal to the product of (A) the number of shares of Company common stock subject to the option immediately before the Effective Time multiplied by (B) 0.01; and (ii) the per share exercise price for each Surviving Corporation Share issuable upon exercise of such option is equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (A) the exercise price per share of such option immediately before the Effective Time by (B) 0.01."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options, together representing a right to purchase 1,501,240 shares, consist of (i) 750,620 time-vesting options and (ii) 750,620 performance-vesting options. Time-vesting options are subject to a five-year time-based vesting schedule, with 20% vesting on September 4, 2020 and the remainder vesting in 16 equal installments every three months thereafter. Performance-vesting options vest over a five-year performance period commencing in 2019, with 20% of the stock options eligible to vest each year of the performance period based on achievement of certain financial metrics."}],"balance_after":0,"derivative":{"exercise_price":7.94,"expiration_date":"2030-03-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":525434},"source":{"system":"sec-edgar","filing":"0000950103-22-017700","document":"dp182275_4-farrell.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1188757/000095010322017700/dp182275_4-farrell.xml","form_type":"4"}},{"id":2138178,"issuer":{"id":123140,"kind":"organization","name":"Convey Health Solutions Holdings, Inc.","symbol":"CNVY"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock, par value $0.01 per share","published_at":"2022-10-12T19:26:16.000Z","date":"2022-10-07","kind":"disposition_to_issuer","acquired":false,"shares":163373,"price":10.5,"value":1715416.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On October 7, 2022 (the \"Closing Date\"), Convey Health Solutions Holdings, Inc. (the \"Company\") completed the transaction pursuant to which Commodore Merger Sub 2022, Inc. (\"Merger Sub\") merged with and into the Company (the \"Merger\") with the Company surviving the Merger (the \"Surviving Corporation\"). Subject to the terms and conditions of the Agreement and Plan of Merger, dated as of June 20, 2022, by and among Commodore Parent 2022, LLC, Merger Sub and the Company (the \"Merger Agreement\"), at the Effective Time (as defined in the Merger Agreement), each of the reporting person's shares of Company common stock issued and outstanding immediately prior to the Effective Time and designated as Rollover Shares (as defined in the Merger Agreement) was automatically converted into 0.01 shares of common stock of the Surviving Corporation (the \"Surviving Corporation Shares\")."},{"field":"security","element":"securityTitle","label":"F2","text":"In connection with the closing of the Merger, the Company notified the New York Stock Exchange (the \"NYSE\") on October 6, 2022 of the anticipated closing of the Merger on the Closing Date and that trading of the shares of Company common stock should be suspended and listing of the Company common stock on the NYSE should be removed prior to the opening of business on the Closing Date. On October 6, 2022, the closing price of a share of Company common stock was $10.51 per share."},{"field":"security","element":"securityTitle","label":"F3","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's shares of Company common stock issued and outstanding immediately prior to the Effective Time and not designated as Rollover Shares was converted into the right to receive $10.50 per share in cash, without interest."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's shares of Company common stock issued and outstanding immediately prior to the Effective Time and not designated as Rollover Shares was converted into the right to receive $10.50 per share in cash, without interest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On October 7, 2022 (the \"Closing Date\"), Convey Health Solutions Holdings, Inc. (the \"Company\") completed the transaction pursuant to which Commodore Merger Sub 2022, Inc. (\"Merger Sub\") merged with and into the Company (the \"Merger\") with the Company surviving the Merger (the \"Surviving Corporation\"). Subject to the terms and conditions of the Agreement and Plan of Merger, dated as of June 20, 2022, by and among Commodore Parent 2022, LLC, Merger Sub and the Company (the \"Merger Agreement\"), at the Effective Time (as defined in the Merger Agreement), each of the reporting person's shares of Company common stock issued and outstanding immediately prior to the Effective Time and designated as Rollover Shares (as defined in the Merger Agreement) was automatically converted into 0.01 shares of common stock of the Surviving Corporation (the \"Surviving Corporation Shares\")."}],"balance_after":4734,"source":{"system":"sec-edgar","filing":"0000950103-22-017700","document":"dp182275_4-farrell.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188757/000095010322017700/dp182275_4-farrell.xml","form_type":"4"}},{"id":2229090,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2022-06-17T22:32:59.000Z","date":"2022-06-16","kind":"exercise","acquired":true,"shares":5765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to his continued service through the vesting date."}],"balance_after":5765,"derivative":{"exercise_price":62.1,"exercise_date":"2023-06-16","expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":5765},"source":{"system":"sec-edgar","filing":"0001209191-22-038092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919122038092/doc4.xml","form_type":"4"}},{"id":2229089,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T22:32:59.000Z","date":"2022-06-16","kind":"exercise","acquired":true,"shares":355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock."}],"balance_after":6567,"source":{"system":"sec-edgar","filing":"0001209191-22-038092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919122038092/doc4.xml","form_type":"4"}},{"id":2314063,"issuer":{"id":123140,"kind":"organization","name":"Convey Health Solutions Holdings, Inc.","symbol":"CNVY"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2022-03-30T16:41:31.000Z","date":"2022-03-28","kind":"grant","acquired":true,"shares":355561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents 355,561 restricted stock units. Restricted stock units are subject to a four year time-based vesting schedule with 25% vesting on March 28, 2023, and the remainder vesting in 12 equal installments every three months thereafter, subject to Mr. Farrell's continued service with Convey Health Solutions Holdings, Inc. (the \"Issuer\") through the applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents 355,561 restricted stock units. Restricted stock units are subject to a four year time-based vesting schedule with 25% vesting on March 28, 2023, and the remainder vesting in 12 equal installments every three months thereafter, subject to Mr. Farrell's continued service with Convey Health Solutions Holdings, Inc. (the \"Issuer\") through the applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents 355,561 restricted stock units. Restricted stock units are subject to a four year time-based vesting schedule with 25% vesting on March 28, 2023, and the remainder vesting in 12 equal installments every three months thereafter, subject to Mr. Farrell's continued service with Convey Health Solutions Holdings, Inc. (the \"Issuer\") through the applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in common stock."}],"balance_after":355561,"derivative":{"underlying":"Common Stock, par value $0.01 per share","underlying_shares":355561},"source":{"system":"sec-edgar","filing":"0001104659-22-040170","document":"tm2210674-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188757/000110465922040170/tm2210674-5_4seq1.xml","form_type":"4"}},{"id":2655332,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2021-06-25T21:54:11.000Z","date":"2021-06-24","kind":"exercise","acquired":true,"shares":850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on the earlier of June 24, 2022 or the Corporation's 2022 Annual Shareholders Meeting."}],"balance_after":850,"derivative":{"exercise_price":154.96,"exercise_date":"2022-06-24","expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":850},"source":{"system":"sec-edgar","filing":"0001209191-21-043359","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121043359/doc4.xml","form_type":"4"}},{"id":2655331,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-25T21:54:11.000Z","date":"2021-06-24","kind":"exercise","acquired":true,"shares":404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The restrictions on the 404 restricted shares of common stock lapse on the earlier of June 24, 2022 or the Corporation's 2022 Annual Meeting, subject to Mr. Farrell's continued service through that date."}],"balance_after":6212,"source":{"system":"sec-edgar","filing":"0001209191-21-043359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121043359/doc4.xml","form_type":"4"}},{"id":2660504,"issuer":{"id":123140,"kind":"organization","name":"Convey Health Solutions Holdings, Inc.","symbol":"CNVY"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock, par value $0.01 per share","published_at":"2021-06-21T06:09:30.000Z","date":"2021-06-18","kind":"purchase","acquired":true,"shares":45000,"price":13,"value":585000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $12.82 to $13.10 per share. The reporting person hereby undertakes to provide to Convey Holding Parent, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":636862,"source":{"system":"sec-edgar","filing":"0001104659-21-082935","document":"tm2120200-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188757/000110465921082935/tm2120200-1_4seq1.xml","form_type":"4"}},{"id":2692344,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2021-05-28T20:31:11.000Z","date":"2021-05-28","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":5.54,"exercise_date":"2017-06-24","expiration_date":"2026-06-23","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-036545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121036545/doc4.xml","form_type":"4"}},{"id":2692343,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2021-05-28T20:31:11.000Z","date":"2021-05-26","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.14,"exercise_date":"2017-01-01","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-036545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121036545/doc4.xml","form_type":"4"}},{"id":2692342,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T20:31:11.000Z","date":"2021-05-28","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":150,"value":750000.0,"ownership":{"direct":true},"balance_after":5808,"source":{"system":"sec-edgar","filing":"0001209191-21-036545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121036545/doc4.xml","form_type":"4"}},{"id":2692341,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T20:31:11.000Z","date":"2021-05-28","kind":"exercise","acquired":true,"shares":5000,"price":5.54,"value":27700.0,"ownership":{"direct":true},"balance_after":10808,"source":{"system":"sec-edgar","filing":"0001209191-21-036545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121036545/doc4.xml","form_type":"4"}},{"id":2692340,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T20:31:11.000Z","date":"2021-05-26","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":135,"value":675000.0,"ownership":{"direct":true},"balance_after":5808,"source":{"system":"sec-edgar","filing":"0001209191-21-036545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121036545/doc4.xml","form_type":"4"}},{"id":2692339,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T20:31:11.000Z","date":"2021-05-26","kind":"exercise","acquired":true,"shares":5000,"price":7.14,"value":35700.0,"ownership":{"direct":true},"balance_after":10808,"source":{"system":"sec-edgar","filing":"0001209191-21-036545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121036545/doc4.xml","form_type":"4"}},{"id":2702046,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2021-05-21T20:06:58.000Z","date":"2021-05-19","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":5.54,"exercise_date":"2017-06-24","expiration_date":"2026-06-23","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-034878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121034878/doc4.xml","form_type":"4"}},{"id":2702045,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T20:06:58.000Z","date":"2021-05-19","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":120,"value":600000.0,"ownership":{"direct":true},"balance_after":5808,"source":{"system":"sec-edgar","filing":"0001209191-21-034878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121034878/doc4.xml","form_type":"4"}},{"id":2702044,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T20:06:58.000Z","date":"2021-05-19","kind":"exercise","acquired":true,"shares":5000,"price":5.54,"value":27700.0,"ownership":{"direct":true},"balance_after":10808,"source":{"system":"sec-edgar","filing":"0001209191-21-034878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121034878/doc4.xml","form_type":"4"}},{"id":2709473,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2021-05-18T20:47:49.000Z","date":"2021-05-17","kind":"exercise","acquired":false,"shares":5328,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5000,"derivative":{"exercise_price":7.14,"exercise_date":"2016-07-08","expiration_date":"2025-12-31","underlying":"Common Stock","underlying_shares":5328},"source":{"system":"sec-edgar","filing":"0001209191-21-033541","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121033541/doc4.xml","form_type":"4"}},{"id":2709472,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-18T20:47:49.000Z","date":"2021-05-17","kind":"disposition_to_issuer","acquired":false,"shares":5328,"price":113.87,"value":606699.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $109.86 to $117.81, inclusive."}],"balance_after":5808,"source":{"system":"sec-edgar","filing":"0001209191-21-033541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121033541/doc4.xml","form_type":"4"}},{"id":2709471,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-18T20:47:49.000Z","date":"2021-05-17","kind":"exercise","acquired":true,"shares":5328,"price":7.14,"value":38041.92,"ownership":{"direct":true},"balance_after":11136,"source":{"system":"sec-edgar","filing":"0001209191-21-033541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919121033541/doc4.xml","form_type":"4"}},{"id":3070691,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-04T21:21:53.000Z","date":"2020-07-30","kind":"grant","acquired":true,"shares":2117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restrictions on the 2117 restricted shares of common stock awarded on his election to the Board of Directors lapse on the earlier of July 30, 2021 or the Corporation's 2021 Annual Meeting, subject to his continued service through that date."}],"balance_after":5808,"source":{"system":"sec-edgar","filing":"0001209191-20-044762","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919120044762/doc4.xml","form_type":"4"}},{"id":3093739,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T21:05:04.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will become exercisable on July 1, 2021, based upon continued service on the board of directors."}],"balance_after":40000,"derivative":{"exercise_price":0.8263,"expiration_date":"2030-07-01","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-20-012541","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220012541/ownership.xml","form_type":"4"}},{"id":3469423,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-04T01:18:36.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will become exercisable on June 30, 2020, based upon continued service on the board of directors."}],"balance_after":40000,"derivative":{"exercise_price":1.03,"expiration_date":"2029-06-30","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-19-041310","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919119041310/doc4.xml","form_type":"4"}},{"id":3480719,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2019-06-24T21:24:40.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":8536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest in full on the earlier of June 20, 2020 or the Corporation's 2020 Annual Meeting, subject to Mr. Farrell's continued service through the vesting date."}],"balance_after":8536,"derivative":{"exercise_price":29.39,"exercise_date":"2020-06-20","expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":8536},"source":{"system":"sec-edgar","filing":"0001209191-19-038819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919119038819/doc4.xml","form_type":"4"}},{"id":3877045,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Shares","published_at":"2018-07-03T22:16:40.000Z","date":"2018-07-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will become exercisable on June 30, 2019, based upon continued service on the board of directors."}],"balance_after":40000,"derivative":{"exercise_price":2.06,"expiration_date":"2023-06-30","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-041298","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118041298/doc4.xml","form_type":"4"}},{"id":3891716,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-18T20:45:16.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":3691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restrictions on the 3,691 restricted shares of common stock lapse on the earlier of June 14, 2019 or the Corporation's 2019 Annual Meeting, subject to Mr. Farrell's continued service through that date."}],"balance_after":3691,"source":{"system":"sec-edgar","filing":"0001209191-18-038346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919118038346/doc4.xml","form_type":"4"}},{"id":3991010,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2018-03-19T21:12:41.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":1206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These stock options vest in full on the earlier of June 14, 2018 or the Corporation's 2018 Annual Meeting, subject to Mr. Farrell's continued service through the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest in full on the earlier of June 14, 2018 or the Corporation's 2018 Annual Meeting, subject to Mr. Farrell's continued service through the vesting date."}],"balance_after":1206,"derivative":{"exercise_price":16.15,"exercise_date":"2018-06-14","expiration_date":"2028-03-14","underlying":"Common Stock","underlying_shares":1206},"source":{"system":"sec-edgar","filing":"0001209191-18-020641","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919118020641/doc4.xml","form_type":"4"}},{"id":4266114,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Shares","published_at":"2017-07-05T23:41:37.000Z","date":"2017-07-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will become exercisable in four equal quarterly installments after the date of grant on July 1, 2017 based upon continued service on the board of directors."}],"balance_after":20000,"derivative":{"exercise_price":3.15,"expiration_date":"2022-06-30","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-17-043772","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117043772/doc4.xml","form_type":"4"}},{"id":4281696,"issuer":{"id":4851,"kind":"organization","name":"STAAR SURGICAL CO"},"owners":[{"id":82329,"kind":"person","name":"FARRELL STEPHEN C","position":1,"cik":"0001188757","reported_name":"FARRELL STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2017-06-15T20:11:28.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":19841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These 19,841 stock options vest in full on the earlier of June 13, 2017 or the Corporation's 2018 Annual Meeting, subject to Mr. Farrell's continued service through the vesting date."}],"balance_after":19841,"derivative":{"exercise_price":9.6,"exercise_date":"2018-06-13","expiration_date":"2027-06-12","underlying":"Common Stock","underlying_shares":19841},"source":{"system":"sec-edgar","filing":"0001209191-17-040109","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718937/000120919117040109/doc4.xml","form_type":"4"}}]}